Broad-spectrum, "layered" immune support pairing a slow-acting adaptive-immune coordinator (Thymosin Alpha-1, which primes T-cells and NK cells over days-to-weeks) with a fast-acting innate antimicrobial (LL-37, which physically disrupts pathogen membranes on contact). Framed by users as seasonal/preventive support and an adjunct during active infection, not as treatment for any diagnosed disease.
Why it matters
Pairs a slow-acting immune modulator (Thymosin Alpha-1, thought to prime the body's T-cells over days to weeks) with a fast-acting antimicrobial peptide (LL-37, proposed to disrupt bacteria on contact), aiming to cover both layers of defense at once.
The published per-compound doses, timing, cycle length, the mechanism sources give for why it's combined, and the harm-reduction notes — the parts that took the most research to get right — are part of membership.
